Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: CONSEGNA PHARMA INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-12-10 to 2022-12-09
Current total value of award: $1099999.92
Description: LONG DURATION, NOVEL OPIOID MEDICAL COUNTERMEASURE FOR INTRAMUSCULAR INJECTION